# Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19

> **NCT04467151** · PHASE2 · WITHDRAWN · sponsor: **Kashif Khan**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** anti-SARS-CoV-2 plasma
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04467151
- **Lead sponsor:** Kashif Khan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10
- **Primary completion:** 2021-10
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Did not obtain funding to proceed with study
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04467151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04467151, "Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04467151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*